Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
NCT03401047
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:
Estradiol
Sponsor
University of Virginia